Tofogliflozin Delays Portal Hypertension and Hepatic Fibrosis by Inhibiting Sinusoidal Capillarization in Cirrhotic Rats.
Shohei AsadaKosuke KajiNorihisa NishimuraAritoshi KoizumiTakuya MatsudaMisako TanakaNobuyuki YoriokaShinya SatoKoh KitagawaTadashi NamisakiTakemi AkahaneHitoshi YoshijiPublished in: Cells (2024)
Our study provides strong support for tofogliflozin in the prevention of liver cirrhosis-related PH.
Keyphrases